📰 Psychedelic Studies News
Page 3 - Psychedelic Studies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psychedelic Studies. Real-time updates on events, politics, business and more.
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
The experts cited flawed study data and potential safety risks of MDMA, including heart problems.
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
June 4, 2024
Federal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. Advisers to the Food and Drug Administration are scheduled to